Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]

Benefits of metronomic chemotherapy and the aims of the Metronomic Global...

Dr Nicolas André - Hôpital pour Enfants de La Timone, Marseille, France

Benefits of metronomic chemotherapy and the aims of the Metronomic Global Health Initiative ( Dr Nicolas André - Hôpital pour Enfants de La Timone, Marseille, France )

Drug repurposing as an alternative to costly drugs such as herceptin in breast...

Dr Shripad Banavali - Tata Memorial Hospital, Mumbai, India

Drug repurposing as an alternative to costly drugs such as herceptin in breast cancer ( Dr Shripad Banavali - Tata Memorial Hospital, Mumbai, India )

Quality of life and cost advantages of metronomics and drug repurposing

Dr Lisa Hutchinson - Editor of Nature Reviews, London, UK

Quality of life and cost advantages of metronomics and drug repurposing ( Dr Lisa Hutchinson - Editor of Nature Reviews, London, UK )

Diabetes drug, metformin, repurposed for use against several cancers including...

Dr Francesco Bertolini - European Institute of Oncology, Milan, Italy

Diabetes drug, metformin, repurposed for use against several cancers including breast ( Dr Francesco Bertolini - European Institute of Oncology, Milan, Italy )

Betablockers repurposed to treat neuroblastoma

Dr Eddy Pasquier - Children's Cancer Institute Australia, Randwick, Australia

Betablockers repurposed to treat neuroblastoma ( Dr Eddy Pasquier - Children's Cancer Institute Australia, Randwick, Australia )

Advances in multiple myeloma: Expert panel discussion

Prof Pieter Sonneveld; Prof Antonio Palumbo; Prof Marivi Mateos; Prof Meletios...

Advances in multiple myeloma: Expert panel discussion ( Prof Pieter Sonneveld; Prof Antonio Palumbo; Prof Marivi Mateos; Prof Meletios Dimopoulos )

Industry view of targeted therapy combinations in oncology

Dr Susan Galbraith – AstraZeneca, Macclesfield, UK

Industry view of targeted therapy combinations in oncology ( Dr Susan Galbraith – AstraZeneca, Macclesfield, UK )

Impact of biomarker-integrated approaches of targeted therapy for lung cancer...

Prof Waun Ki Hong - University of Texas MD Anderson Cancer Center, Houston, USA

Impact of biomarker-integrated approaches of targeted therapy for lung cancer elimination ( Prof Waun Ki Hong - University of Texas MD Anderson Cancer Center, Houston, USA )

Genomic complexity of metastatic disease and the conundrum of combinations

Prof Razelle Kurzrock - University of California, San Diego, USA

Genomic complexity of metastatic disease and the conundrum of combinations ( Prof Razelle Kurzrock - University of California, San Diego, USA )

Complexity of intra- and inter-pathway loops in colon cancer and melanoma:...

Prof René Bernards - Netherlands Cancer Institute, Amsterdam, The Netherlands

Complexity of intra- and inter-pathway loops in colon cancer and melanoma: Implications for targeted therapies ( Prof René Bernards - Netherlands Cancer Institute, Amsterdam, The Netherlands )

WIN consortium as a basis for forming cross-border collaborations for improving...

Dr Oliver Bogler - MD Anderson Cancer Center, Houston, USA

WIN consortium as a basis for forming cross-border collaborations for improving personalised medicine and palliative care ( Dr Oliver Bogler - MD Anderson Cancer Center, Houston, USA )

Systems medicine approach to optimise drugs and drug combinations for...

Dr Olli Kallioniemi - University of Helsinki, Helsinki, Finland

Systems medicine approach to optimise drugs and drug combinations for individual AML patients ( Dr Olli Kallioniemi - University of Helsinki, Helsinki, Finland )

More from ecancer